oleanolic acid has been researched along with Disease Exacerbation in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 18 (81.82) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, X; Huang, C; Huang, D; Liu, J; Tao, Y; Wang, Y | 1 |
| Capolongo, G; Celentano, S; Pollastro, RM | 1 |
| Claro-Cala, CM; de Sotomayor, MA; Herrera, MD; Miñano, J; Pérez-Montero, M; Quintela, JC; Rodríguez-Rodríguez, AR | 1 |
| Nezu, M; Suzuki, N; Yamamoto, M | 1 |
| Bhattacharjee, N; Dewanjee, S; Dua, TK; Kalita, J; Khanra, R; Manna, P; Nandy, A; Saha, A | 1 |
| Toto, RD | 1 |
| Baigent, C; Lennon, R | 1 |
| Bakris, GL; Block, GA; Chertow, GM; Chin, MP; Goldsberry, A; Heerspink, HJL; Inker, LA; Meyer, CJ; O'Grady, M; Pergola, PE; Wanner, C; Warnock, DG | 1 |
| Appel, GB; Block, GA; Chertow, GM; Chin, MP; Coyne, DW; Goldsberry, A; Kalantar-Zadeh, K; Meyer, CJ; Molitch, ME; Pergola, PE; Raskin, P; Rossing, P; Silva, AL; Spinowitz, B; Sprague, SM | 1 |
| Solomon, R | 1 |
| Appel, G | 1 |
| Cusimano, FA; Getachew, Y; Gopal, P; Reisman, SA; Shay, JW | 1 |
| Bozeman, RG; Kaisani, A; Kim, SB; Kim, W; Richardson, JA; Shay, JW; Wright, WE; Zhang, L | 1 |
| Honkura, Y; Katori, Y; Kawase, T; Matsuo, H; Mizutari, K; Morita, I; Motohashi, H; Murakami, S; Sakiyama, M; Shinomiya, N; Shiotani, A; Yamamoto, M | 1 |
| Clapper, ML; Grubbs, CJ; Juliana, MM; Lubet, RA; McCormick, DL; Steele, VE; Townsend, R | 1 |
| Arbab, AS; Deeb, D; Divine, GW; Dulchavsky, SA; Gao, X; Gautam, SC; Jiang, D; Liu, Y | 1 |
| Ali, MM; Arbab, AS; Deeb, D; Gao, X; Gautam, SC; Iskander, AS; Janic, B; Shankar, A; Varma, NR | 1 |
| Abramowitz, MK; Bauer, C; Hostetter, TH; Melamed, ML; Turner, JM | 1 |
| Boffa, JJ; Chatziantoniou, C; Dussaule, JC; Ronco, P | 1 |
| Pergola, PE; Ruiz, S; Vaziri, ND; Zager, RA | 1 |
| Yamada, G | 1 |
| Gong, Y; Li, P; Li, Y; Shimizu, F; Wang, B; Zu, N | 1 |
5 review(s) available for oleanolic acid and Disease Exacerbation
| Article | Year |
|---|---|
[Bardoxolone: a new potential therapeutic agent in the treatment of autosomal dominant polycystic kidney disease?]
Topics: Clinical Trials as Topic; Disease Progression; Down-Regulation; Early Termination of Clinical Trials; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Failure, Chronic; NF-E2-Related Factor 2; NF-kappa B; Oleanolic Acid; Polycystic Kidney, Autosomal Dominant; Renal Agents | 2019 |
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
Topics: Acute Kidney Injury; Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Glomerular Filtration Rate; Humans; Kelch-Like ECH-Associated Protein 1; Kidney Tubules; Mice; Molecular Targeted Therapy; NF-E2-Related Factor 2; Oleanolic Acid; Oxidative Stress; Proteasome Endopeptidase Complex; Proteolysis; Reactive Oxygen Species; Renal Insufficiency, Chronic; Signal Transduction; Ubiquitination | 2017 |
Treatment of chronic kidney disease.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Diabetes Mellitus, Type 2; Disease Progression; Endothelin-1; Humans; Hypertension; Kidney Failure, Chronic; Oleanolic Acid; Pyridones; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2012 |
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.
Topics: Acute Kidney Injury; Animals; Anti-Infective Agents; Antioxidants; Disease Progression; Humans; Inflammation; Kidney; Kidney Failure, Chronic; NF-E2-Related Factor 2; Oleanolic Acid; Oxidative Stress; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2013 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
2 trial(s) available for oleanolic acid and Disease Exacerbation
| Article | Year |
|---|---|
Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
Topics: Aged; Diabetes Mellitus, Type 2; Disease Progression; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Oleanolic Acid; Renal Dialysis; Treatment Outcome | 2018 |
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.
Topics: Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Obesity; Oleanolic Acid; Renal Insufficiency, Chronic; Waist Circumference | 2018 |
15 other study(ies) available for oleanolic acid and Disease Exacerbation
| Article | Year |
|---|---|
Wilforlide A ameliorates the progression of rheumatoid arthritis by inhibiting M1 macrophage polarization.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cell Polarity; Cells, Cultured; Cytokines; Disease Models, Animal; Disease Progression; Inflammation Mediators; Macrophage Activation; Macrophages; Male; Mice, Inbred DBA; NF-kappa B; Oleanolic Acid; Phytotherapy; Signal Transduction; Synovial Membrane; Toll-Like Receptor 4 | 2022 |
Pomace Olive Oil Concentrated in Triterpenic Acids Restores Vascular Function, Glucose Tolerance and Obesity Progression in Mice.
Topics: Adiposity; Animals; Aorta, Thoracic; Biomarkers; Blood Glucose; Diet, High-Fat; Diet, Mediterranean; Disease Models, Animal; Disease Progression; Insulin Resistance; Male; Mice, Inbred C57BL; Obesity; Oleanolic Acid; Olive Oil; Triterpenes; Vasoconstriction; Vasodilation; Weight Gain | 2020 |
Taraxerol, a pentacyclic triterpenoid, from Abroma augusta leaf attenuates diabetic nephropathy in type 2 diabetic rats.
Topics: Animals; Computer Simulation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Hyperglycemia; Inflammation; Malvaceae; Molecular Docking Simulation; Oleanolic Acid; Plant Leaves; Rats; Rats, Wistar; Streptozocin; Up-Regulation | 2017 |
Bardoxolone-the Phoenix?
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Glomerular Filtration Rate; Heart Failure; Humans; Nephritis, Hereditary; Oleanolic Acid; Renal Insufficiency, Chronic | 2018 |
Should We Increase GFR with Bardoxolone in Alport Syndrome?
Topics: Albuminuria; Anti-Inflammatory Agents; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Glomerular Filtration Rate; Heart Failure; Humans; Nephritis, Hereditary; Oleanolic Acid; Renal Insufficiency, Chronic | 2018 |
New Approach to Slowing the Progression of Chronic Kidney Disease.
Topics: Disease Progression; Healthy Volunteers; Humans; Oleanolic Acid; Renal Insufficiency, Chronic | 2019 |
Detecting and controlling diabetic nephropathy: what do we know?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Humans; Hypoglycemic Agents; Oleanolic Acid; Renin-Angiotensin System | 2013 |
The Synthetic Triterpenoid RTA 405 (CDDO-EA) Halts Progression of Liver Fibrosis and Reduces Hepatocellular Carcinoma Size Resulting in Increased Survival in an Experimental Model of Chronic Liver Injury.
Topics: Animals; Carbon Tetrachloride; Cell Line, Tumor; Cytochrome P-450 CYP2E1; Cytokines; Disease Progression; Humans; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oleanolic Acid | 2016 |
Radiation promotes colorectal cancer initiation and progression by inducing senescence-associated inflammatory responses.
Topics: Adenomatous Polyposis Coli; Aging; Animals; Colorectal Neoplasms; Disease Models, Animal; Disease Progression; DNA Damage; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Mice, Inbred C57BL; Mice, Knockout; Mutation; Oleanolic Acid; Oxidative Stress; Proton Therapy; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Tumor Suppressor Protein p53; Whole-Body Irradiation | 2016 |
NRF2 Is a Key Target for Prevention of Noise-Induced Hearing Loss by Reducing Oxidative Damage of Cochlea.
Topics: Animals; Cochlea; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Genetic Predisposition to Disease; Glutathione; Hearing Loss, Noise-Induced; Imidazoles; Lipid Peroxidation; Mice; Mice, Knockout; NF-E2-Related Factor 2; Oleanolic Acid; Oxidative Stress; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Protective Agents; Reactive Oxygen Species | 2016 |
5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target?
Topics: Activation, Metabolic; Animals; Antineoplastic Agents; Antioxidant Response Elements; Carcinogens; Disease Progression; Female; Imidazoles; Intestinal Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred AKR; Neoplasms, Experimental; Oleanolic Acid; Rats; Rats, Sprague-Dawley; Tongue Neoplasms | 2016 |
Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling.
Topics: Adenocarcinoma; Animals; Animals, Genetically Modified; Apoptosis; Blotting, Western; Cell Proliferation; Disease Progression; Female; Humans; Immunoenzyme Techniques; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Oleanolic Acid; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction | 2011 |
MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP).
Topics: Animals; Chemoprevention; Disease Progression; Magnetic Resonance Imaging; Male; Mice; Mice, Transgenic; Oleanolic Acid; Prostate; Prostatic Neoplasms; Seminal Vesicles | 2011 |
[Chronic kidney disease, new therapeutic approaches].
Topics: Angiotensin-Converting Enzyme Inhibitors; Disease Progression; Drug Therapy, Combination; Endothelin Receptor Antagonists; Humans; Oleanolic Acid; Prognosis; Protein Kinase Inhibitors; Renal Insufficiency, Chronic; Treatment Outcome | 2012 |
Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomerulonephritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Blood Pressure; Blotting, Western; CD8-Positive T-Lymphocytes; Collagen Type I; Disease Progression; Female; Fluorescent Antibody Technique; Gene Expression Regulation; Glomerulonephritis, Membranoproliferative; Isoantibodies; Kidney Glomerulus; Macrophages; Mesangial Cells; Oleanolic Acid; Proteinuria; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Saponins; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |